Efficacy of furunculosis vaccines in turbot, Scophthalmus maximus (L.): evaluation of immersion, oral and injection delivery

• Published in: Journal of Fish Diseases
• Main Authors: Santos, Y, García‐Marquez, S, Pereira, P G, Pazos, F, Riaza, A, Silva, R, El Morabit, A, Ubeira, F M
• Format: Article in Journal/Newspaper
• Language: English
• Published: Wiley 2005
• Subjects: Scophthalmus maximus; Turbot
• Online Access: http://dx.doi.org/10.1111/j.1365-2761.2005.00610.x; https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2761.2005.00610.x; https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2761.2005.00610.x

Abstract The commercial furunculosis vaccine Aquavac Furovac 5 and an autogenous vaccine, based on the challenge strain, induced immune protection in turbot, Scophthalmus maximus (L.), as shown in challenge tests 120 days post‐immunization by injection (relative percentage of survival, RPS = 72–99%). This protective effect lasted for at least 6 months post‐immunization at appreciable levels (RPS = 50–52%). Neither the autogenous vaccine nor the commercial vaccine was able to induce significant levels of protection against Aeromonas salmonicida in turbot when administered by immersion. Antibody levels were high or moderate in fish vaccinated by injection with the different vaccines and very low in fish vaccinated by immersion. The field results show that delivering an oral boost after the primary vaccination by injection did not enhance protection of turbot against furunculosis and that water‐based (autogenous vaccine) and oil adjuvanted (Alpha Ject 1200) vaccines administered by injection conferred similar levels of protection (RPS > 80%) in turbot.